Associations of an overall healthy lifestyle with the risk of metabolic dysfunction-associated fatty liver disease
Abstract Background Metabolic dysfunction-associated fatty liver disease (MAFLD) affects up to one-third of the global population. Since no approved pharmacotherapy for MAFLD is available, lifestyle modification remains the cornerstone of clinical care. Our study aims to evaluate the association of...
Saved in:
| Main Authors: | Caimei Yuan, Chengjing Zhang, Xin Geng, Chengwu Feng, Yang Su, Yinfan Wu, Ying Wang, Li Chen, Qiurong Ding, Trudy Voortman, Hongyang Wang, Geng Zong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | BMC Public Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12889-024-20663-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beyond medication: Unveiling the role of diet and lifestyle in fatty liver disease management
by: Iahtisham-Ul-Haq, et al.
Published: (2025-06-01) -
Lifestyle factors associated with being overweight and obesity in children and adolescents: a cross-sectional study in Zhejiang, China
by: Xiaoting Pan, et al.
Published: (2025-03-01) -
Ultrasound assessment of hepatomegaly and metabolically-associated fatty liver disease among a sample of children: a pilot project
by: Bárbara L. Riestra-Candelaria, et al.
Published: (2025-04-01) -
Liver steatosis is positively associated with plasminogen activator inhibitor-1 in apparently healthy individuals with overweight and obesity: A FibroScan-Based Cross-Sectional study
by: Giuseppe Lisco, et al.
Published: (2025-04-01) -
Classification of overweight/obesity among Saudi adolescents relative to lifestyle behaviors using the IOTF or WHO reference standards
by: Hazzaa M. Al-Hazzaa, et al.
Published: (2025-08-01)